These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 84470)

  • 1. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
    Zachariae H; Thestrup-Pedersen K; Søgaard H
    Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
    Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
    Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
    Arundell FD; Chan WH
    Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
    Volden G; Larsen TE
    Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
    Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical chemotherapy of mycosis fungoides.
    Grekin DA; Zackheim HS; Epstein EH
    Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical, intratumor and intravenous nitrogen mustard in the treatment of mycosis fungoides (author's transl)].
    Sánchez Yus E; Vanaclocha Sebastián F
    Med Clin (Barc); 1980 Sep; 75(5):199-202. PubMed ID: 6999251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O; Fischer T; Nordentoft A; Zachariae H
    Cutis; 1980 Feb; 25(2):155-7, 160-1. PubMed ID: 6153595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of mycosis fungoides with ointment-based mechlorethamine.
    Price NM; Deneau DG; Hoppe RT
    Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K; Grunnet E; Zachariae H
    Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
    Vonderheid EC; Dellatorre DL; Van Scott EJ
    Arch Dermatol; 1981 Sep; 117(9):586-9. PubMed ID: 6457569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
    Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
    Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K; Hammar H; Molin L; Volden G
    Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.
    Molin L; Thomsen K; Volden G; Aronsson A; Hammar H; Hellbe L; Wantzin GL; Roupe G
    Acta Derm Venereol; 1987; 67(3):232-6. PubMed ID: 2442936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.